ClinicalTrials.gg
CompletedNCT04597645Updated May 3, 2024

Prader-Willi Syndrome Body Composition

An interventional study of Therapeutic elastic band resistance training in Prader Labhart Willi Syndrome, Body Weight Changes and Sarcopenia, sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. Completed at 1 site in Taiwan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-05-03.

Sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled May 2020, registered Aug 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Adults aged over 18 years, with the diagnosis of Prader-willi syndrome will be recruited through the hospital's outpatient clinic for either as intervention group receiving therapeutic elastic band training, or as control group receiving usual care for a total of 16 weeks. Body composition, physical capacity, and serum changes will be assessed before and after the intervention.

Read the detailed description

Participants that fulfill the inclusion criteria will be assigned into one of the two arms: elastic band intervention group (EB) or control group (CG). Both groups will received a baseline: dual X-ray absorptiometry body composition, physical capacity, and serum markers examinations. EB will then receive a 16-week progressive elastic band resistance exercise training, while the CG will receive usual care. After the 16 weeks from the baseline assessment, a followed-up: dual X-ray absorptiometry body composition, physical capacity, and serum examinations will be assessed.

02

Conditions studied

  • Prader Labhart Willi Syndrome
  • Body Weight Changes
  • Sarcopenia

Keywords

  • Prader Willi Syndrome
  • Body composition
  • Sarcopenia
  • Resistance training
  • Physical capacity
03

In context

Prader-Willi Syndrome

142 studies on the registry are indexed under Prader-Willi Syndrome; 23 are open to participants now.

This study's enrollment of 20 is below the median of 30 across 99 interventional studies indexed under Prader-Willi Syndrome.

Browse Prader-Willi Syndrome studies →

Lead sponsor

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation is the lead sponsor of 58 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-65 years old.
  • Genetically diagnosis of Prader-willi syndrome.
  • Must be able to follow and understand mandarin instructions and cooperate to the exercise assessments and/or training.

Exclusion criteria

Exclusion Criteria:

  • Prader-willi syndrome individuals unable to sit, stand and walk independently which make physical capacity assessment difficult.
  • Severe arthritis, fracture, or other musculoskeletal deformities that interfere with exercise training.
  • Severe cognitive impairment who cannot read, write the informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Elastic band (EB)

    EB group participants who are attending sheltered employment will received Elastic Thera band training program two times per week (once supervised and guided by a trained physical therapist and the other supervised by educational trainer) over 16 weeks for a total of 32 sessions.

    Other: Therapeutic elastic band resistance training

  • No intervention
    Control group (CG)

    Control group participants will receive usual care.

Interventions

  • OtherTherapeutic elastic band resistance training

    A16-week therapeutic program using Elastic Thera Band will be taught. The exercises are designed to train specific major muscle groups, strengthen the motivation of participants, and facilitate home-based compliance. The program will be performed two times per week (once supervised and guided by a trained physical therapist and the other supervised by educational trainers) over 16 weeks for a total of 32 sessions. Each session supervised by a physical therapist last for 60 minutes, including a 5-minute warm-up consisting of light-intensity aerobic and dynamic stretching exercises, followed by 50 minutes of EB exercise and a 5-minute period of cool-down and static stretching exercises.

06

What researchers measure

Primary outcomes

  1. Change in lean tissue mass and adipose tissue mass

    Lean tissue mass and adipose tissue mass will be determined by dual energy x-ray absorptiometry (DXA) (Hologic Densitometer Discovery A, USA).

    Time frame: Baseline and 4 month follow up

  2. Change in body mass index

    Body mass index will be calculated as the body mass in kilograms divided by the square of the height in meters.

    Time frame: Baseline and 4 month follow up

Secondary outcomes

  1. Change in grip muscle strength

    A baseline hydraulic dynamometer will be used to assess the grip muscle strength. The upper extremity muscle quality (ratio of muscular strength to muscle mass) will be calculated by dividing handgrip strength by arm lean mass.

    Time frame: Baseline and 4 month follow up

  2. Change in 30-second sit to stand test

    The 30-second sit to stand test assesses endurance by counting the number of sit to stand ups achieved.

    Time frame: Baseline and 4 month follow up

  3. Change in timed up and go test

    The timed up and go test measures the time required to rise from a chair, walk a 3-meter-long line on the floor, turn around, walk back, and sit down again.

    Time frame: Baseline and 4 month follow up

  4. Change in two minute step up test

    The two minute step up test measures aerobic endurance by having the subject marching in place for two minutes, lifting alternatively the knees to a midway between patella and iliac crest height of a tape (marked at the wall).

    Time frame: Baseline and 4 month follow up

  5. Change in Berg balance scale

    Berg balance scale assesses simple mobility function tasks (sit unsupported, sit-to-stand, stand to sit, stand unsupported, transfer, stand with eyes closed and feet together) and more difficult balance tasks (turn to look behind, retrieve object from floor, turn 360 degrees, reach forward with an outstretched arm, tandem stand, place alternate foot on stool, and single leg stand). It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4. A maximum scoring of 56 indicates functional balanced, while scoring\< 45 indicates higher risk of falling.

    Time frame: Baseline and 4 month follow up

  6. Change in lipid profile

    Measurements of serum levels of total cholesterol, triglyceride, low-density lipoprotein, and high-density lipoprotein will be determined using biochemical automatic analyzer according to the manufacturer's recommendations and established methods in the literature.

    Time frame: Baseline and 4 month follow up

  7. Change in fasting glucose

    Measurements of serum levels of fasting glucose will be determined using biochemical automatic analyzer according to the manufacturer's recommendations and established methods in the literature.

    Time frame: Baseline and 4 month follow up

  8. Change in glycated hemoglobin

    Measurements of the glycated hemoglobin (HbA1c) of fasting glucose will be determined using biochemical automatic analyzer according to the manufacturer's recommendations and established methods in the literature.

    Time frame: Baseline and 4 month follow up

Other outcomes

  1. Change in appendicular skeletal muscle mass and lower extremity skeletal muscle mass

    The appendicular skeletal muscle mass (ASM) will be obtained from the dual energy x-ray absorptiometry (DXA) (Hologic Densitometer Discovery A, USA) measurement, excluding the bone mass from the mass of the extremities, from which fat mass is already excluded. ASM (kg)=lean body mass of extremity - bone mass of extremity. The lower extremity skeletal muscle mass (LESM) will be obtained from the dual energy x-ray absorptiometry (DXA) (Hologic Densitometer Discovery A, USA) measurement, by excluding the bone mass of the lower extremity, from which fat mass is already excluded. LESM (kg)=lean body mass of lower extremity - bone mass of lower extremity.

    Time frame: Baseline and 4 month follow up

  2. Change in skeletal muscle mass index and lower extremity skeletal muscle mass index

    Skeletal muscle mass index (SMI) (%) will be calculated using the values measured via the dual energy x-ray absorptiometry (DXA) (Hologic Densitometer Discovery A, USA) as follow= ASM (kg)/body weight (kg)×100 Lower extremity skeletal muscle mass (LESM) (%) will be calculated using the values measured via the dual energy x-ray absorptiometry (DXA) (Hologic Densitometer Discovery A, USA) as follow= LESM (kg)/lower extremity body weight (kg)×100)

    Time frame: Baseline and 4 month follow up

07

Study locations

1 site
  • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
    New Taipei City, 231, Taiwan
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) is not planned to be shared.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2020 to primary completion in Jul 2021, 14 months.

Of 20 interventional studies with no phase under Prader-Willi Syndrome, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 43. This study's 14 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2020
First posted
Oct 22, 2020
StartActual
May 6, 2020
Primary completionActual
Jul 31, 2021
CompletionActual
Jul 31, 2021
Last update
May 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04597645
Lead sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Responsible party
Sponsor
First posted
Oct 22, 2020
Start date
May 6, 2020
Primary completion
Jul 31, 2021
Completion
Jul 31, 2021
Last update
May 3, 2024

Study contacts

Valeria Chiu, MD
principal investigator · Taichung Tzu Chi Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion